Suppressioosis in COLO 205 cells by the phorbol ester TPA may be mediated by the PKC isoenzyme α

International Journal of Oncology

Volumn 10, Issue 6, 1997, Pages 1119-1123

  Weiss, Elfriede ^a   Von Reyher, Ulrike ^b   Kein, Walter ^a   Möller, Peter ^b   Krammer, Peter H ^a   Marks, Friedrich ^a   Gschwendt, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

APO 1 FAS CD95; Apoptosis; Colon carcinoma cells; Indomethacin; Protein kinase C ; TPA

Indexed keywords

BRYOSTATIN 1; DNA; FAS ANTIGEN; INDOMETACIN; ISOENZYME; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CELL LYSATE; COLON CARCINOMA; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; ETIOLOGY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PREVENTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 8344288221     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chinnaiyan AM and Dixit VM: The cell death machine. Curr Biol 8: 555-562, 1996.
2. Vaux DL and Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239-2244, 1996.
3. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC and Williams GT: Apoptosis: molecular regulation of cell death. Eur J Biochem 236: 1-26, 1996.
4. Lavin MF, Watters D and Song Q: Role of protein kinase in apoptosis. Experientia 52: 979-994, 1996.
5. Grant S and Jarvis WD: Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy. Clin Cancer Res 2: 1915-1920, 1996.
6. Marks F and Gschwendt M: Protein kinase C. In: Protein Phosphorylation. Marks F (ed). VCH, Weinheim, New York, pp81-116, 1996.
7. Liu J-P: Protein kinase C and its substrates. Mol Cell Endocrinol 116: 1-29, 1996.
8. Dhein J, Daniel PT, Trauth BC, Oehm A, Möller P and Krammer PH: Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149: 3166-3173, 1992.
9. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M and Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
10. C1989.
11. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
12. Geiges D, Marks F and Gschwendt M: Loss of protein kinase Cδ from human HaCaT keratinocytes upon Ras transfection is mediated by TGFα. Exp Cell Res 219: 299-303, 1995.
13. Von Reyher U, Sträte J, Kittstein W, Gschwendt M, Krammer PH and Möller P: Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res (In press).
14. Prendiville J, Crowther D, Thatcher N, Woll PJ, Fox BW, McGown A, Testa N, Stern P, McDermott R, Potter M and Pettit GR: A phase 1 study of intravenous bryostatin 1 in patients with advanced cancer. Br J Cancer 68: 418-424, 1993.
15. Gschwendt M, Fürstenberger G, Rose-John S, Rogers M, Kittstein W, Pettit GR, Herald CL and Marks F: Bryostatin 1, an activator of protein kinasc C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro, Carcinogenesis 9: 555-562, 1988.
16. Shiff SJ, Koutsos MI, Qiao L and Rigas B: Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effect on cell cycle and apoptosis. Exp Cell Res 222: 179-188, 1996.
17. Chmura SJ, Nodzenski E, Weichselbaum RR and Quintans J: Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res 56: 2711-2714, 1996.
18. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I and Fuks Z: Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 54: 2591-2597, 1994.
19. Jarvis WD, Fomari FA, Browning JL, Gewirtz DA, Kolesnick RN and Grant S: Attenuation of ceramide-induced apoptosis by diglyceride and pharmacological activators of protein kinase C in human myeloid leukemia cells. J Biol Chem 269: 31685-31692, 1994.
20. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, Hannun Y and Seldin MF: Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 92: 8443-8447, 1995.
21. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS and Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800-803, 1996.
22. Yazaki T, Ahmad S, Chahlavi A, Zylber-Katz E, Dean NM, Rabkin SD, Martuza RL and Glazer RI: Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α phosphorothioate oligodeoxynucleotide. Mol Pharmacol 50: 236-242, 1996.
23. Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nickiin P, Meister L, Ziel R, Geiger T, Muller M and Fabbro D: Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res 56: 3499-3507, 1996.
24. Lee JY, Hannun YA and Obeid LM: Ceramide inactivates cellular protein kinase Cα.J Biol Chem 271: 13169-13174, 1996.
25. Derer W, Schulz J, Fusenig NE, Stark H-J, Geiges D and Gschwendt M: Spontaneous malignant transformation in vitro of the human epidermal keratinocyte line HaCaT. Arch Dermatol Res 288: 300, 1996.
26. Muzio M, Chinnaian AM, Kischkel FC, O'Rourke K, Shevchenko A, Scaffidi C, Zhang M, Ni J, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827, 1996.